Occurrence of Cold Agglutinin Disease among Patients with Autoimmune Hemolytic Anemia: A Hungarian Single-Center Experience [0.03%]
匈牙利单中心自身免疫性溶血性贫血患者中冷凝集素病的发生情况
Boglárka Brugós,Márta Kerecsenyi,Zsófia Simon et al.
Boglárka Brugós et al.
Introduction: Cold agglutinin disease is a rare autoimmune hemolytic anemia, a low-grade lymphoproliferative disease. Our objective was to determine the occurrence of cold agglutinin disease among patients with autoimmune...
The Landscape of Advanced Therapy Medicinal Products in Slovenian Transfusion Medicine: A Review of Past and Future Outlook [0.03%]
斯洛文尼亚输血医学中先进治疗药物的现状与展望：过去和未来的回顾性分析
Urban Švajger,Primož Poženel,Primož J Rožman et al.
Urban Švajger et al.
Background: Advanced therapy medicinal products (ATMPs) represent a transformative class of biological therapies, including gene therapies, somatic cell therapies, and tissue-engineered products, designed to address compl...
ABO Incongruency Increases Risk for Necrotizing Enterocolitis in Preterm Neonates [0.03%]
ABO血型不和增加极低体重早产儿坏死性小肠结肠炎的风险
Jeremy A Sandgren,Numra A Aleem,J Brooks Jackson et al.
Jeremy A Sandgren et al.
Introduction: Preterm neonates are at high risk for complications, and inflammation has been implicated in many of these pathologies. ABO incongruency occurs when the maternal and neonatal blood types are different and ma...
Martin Olivieri,Christoph Königs
Martin Olivieri
Background: Hemophilia A and B are X-linked inherited bleeding disorders resulting from factor VIII or IX deficiency and are associated with substantial morbidity beginning in early childhood. Recurrent musculoskeletal bl...
Katharina Holstein,Tido Bajorat,Rafael Beck et al.
Katharina Holstein et al.
Background: For prevention of musculoskeletal bleeds in patients with severe and moderate haemophilia A (HA) or B (HB), prophylaxis is recommended. Clotting factor concentrates with standard half-life (SHL) necessitate fr...
Monocyte Monolayer Assay as a Tool in the Early Assessment of the Severity of the Alloantibodies in Patients with Hemolytic Disease of the Fetus and Newborn [0.03%]
单核细胞单层试验在胎儿和新生儿溶血病 allo抗体早期严重性评估中的应用工具
Diego Santoro,Marcelo Ielpi,Guillermo Grottola et al.
Diego Santoro et al.
Introduction: Hemolytic disease of the fetus and newborn (HDFN), caused by the transplacental passage of maternal alloantibodies, can lead to progressive fetal organ failure and death from hydrops fetalis. Because serolog...
Karen Bieback,Peter Bugert
Karen Bieback
A Jehovah's Witness with Acquired Hemophilia A Who Successfully Avoided Blood Transfusions by Receiving Emicizumab [0.03%]
一名通过使用emicizumab成功避免输血的获得性甲型血友病邪 Witnesses患者
Makoto Saito,Atsushi Yasumoto,Masahiro Ieko et al.
Makoto Saito et al.
Introduction: Acquired hemophilia A (AHA) manifests as a significant deficiency in coagulation factor VIII (FVIII) activity caused by the development of autoantibodies against FVIII and results in severe bleeding symptoms...
Mathilde Gavillet,Tobias Gleich-Nagel,Helene Legardeur et al.
Mathilde Gavillet et al.
Introduction: Hemolytic disease of the fetus and newborn (HDFN) is a potentially life-threatening condition caused by maternal alloimmunization against fetal red blood cell (RBC) antigens. While most cases involve well-ch...
Serum Eye Drops: Implementation, Upscaling, and Patient-Centered Care - Insights from a Blood Bank in Western Austria [0.03%]
人乳眼药水：实施、扩大和以患者为中心的护理——来自奥地利西部一家血库的见解
Anita Siller,Harald Schennach,Marco Amato
Anita Siller
Background: Serum eye drops (SEDs) have emerged as an important therapeutic option for the management of severe ocular surface diseases, particularly in cases refractory to conventional treatments. Despite their proven ef...